- 专利标题： METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA
-
申请号： US16010739申请日： 2018-06-18
-
公开(公告)号： US20180289618A1公开(公告)日： 2018-10-11
- 发明人: Timo REUNAMAKI , Pertti PELLINEN , Olli OKSALA , Kari LEHMUSSAARI
- 申请人： Santen Pharmaceutical Co., Ltd. , Asahi Glass Co., LTD.
- 申请人地址： JP Osaka JP Tokyo
- 专利权人： Santen Pharmaceutical Co., Ltd.,Asahi Glass Co., LTD.
- 当前专利权人： Santen Pharmaceutical Co., Ltd.,Asahi Glass Co., LTD.
- 当前专利权人地址： JP Osaka JP Tokyo
- 优先权： EP08397513.6 20080530
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K9/08 ; A61K47/18 ; A61K47/10 ; A61K47/26 ; A61K31/5575 ; A61K47/02
摘要：
The present invention relates to an ophthalmic aqueous composition containing PGF2α analogues for treating ocular hypertension and glaucoma, to a method for treating ocular hypertension and glaucoma by administering said composition to a subject in need of such treatment, and to a method for increasing aqueous solubility and stability of PGF2α analogues in an aqueous composition.
信息查询
